TransMedics Group, Inc.
TMDX Healthcare Medical Devices
TransMedics Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $605.5 million, up 37.1% from fiscal 2024. In the quarter to June 2026, revenue grew 20.7%, EPS fell 59.2%, free cash flow fell 87.6% and total debt rose 68.7%, each against the same quarter a year earlier. Revenue growth for five consecutive years, operating cash flow growth for three; insiders bought in the last twelve months.
Follow TMDX
TransMedics Group, Inc. (TMDX) EV/Sales
As of 16 October 2026, TransMedics Group, Inc. (TMDX) trades at a EV/Sales of 4.2×. Over the past ten years it has ranged from 3.5× (May 2019) to 42.5× (March 2021); the current reading is higher than 3% of that period. That is above the Medical Devices industry median of 2.2× and above the Healthcare sector median of 3.4×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 6.9× | 35.01% |
| FY2024 | 5.1× | (52.91%) |
| FY2023 | 10.8× | (34.72%) |
| FY2022 | 16.6× | 6.15% |
| FY2021 | 15.6× | (0.20%) |
| FY2020 | 15.6× | 65.02% |
| FY2019 | 9.5× | 169.68% |
| FY2018 | 3.5× | 0.00% |
| FY2017 | 3.5× | 0.00% |
| FY2016 | 3.5× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 4.0× | (33.00%) |
| Mar 2026 | 6.0× | (12.70%) |
| Dec 2025 | 6.9× | 0.45% |
| Sep 2025 | 6.8× | (21.98%) |
| 30 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| INSP Inspire Medical Systems, Inc. compare | 1.9× |
| ATEC Alphatec Holdings, Inc. compare | 2.6× |
| NEOG Neogen Corporation compare | 3.6× |
| UFPT UFP Technologies, Inc. compare | 3.8× |
| TMDX TransMedics Group, Inc. | 4.2× |
| IRTC iRhythm Holdings, Inc. compare | 4.4× |
| AXGN AxoGen, Inc. compare | 7.0× |
| ESTA Establishment Labs Holdings Inc. compare | 8.1× |
| BFLY Butterfly Network, Inc. compare | 16.3× |
| Medical Devices industry median | 2.2× |
| Healthcare sector median | 3.4× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)